High Incidence of Ragweed Allergy and Emergence of Covid-19 to Augment Growth of Ragweed Pollen Allergy Treatment Market

Ragweed Pollen Allergy Treatment


 Ragweed pollen is one of the most common causes of seasonal allergies in various countries. Symptoms of ragweed pollen allergy include, runny nose or congestion, coughing or wheezing, sinus pressure, itchy, watery eyes, scratchy throat, and swollen, bluish-colored skin beneath the eyes.

Market Dynamics

High incidence of ragweed allergy is expected to propel growth of the global ragweedpollen allergy treatment market. For instance, according to Asthma and Allergy Foundation of America, ragweed allergy affects 10 to 20% of people in the U.S. Moreover, high prevalence of asthma is also expected to aid in growth of the market. For instance, according to The Global Asthma Report 2018, the prevalence of asthma symptoms was 23% and the prevalence of a medical diagnosis of asthma 12% in Brazil.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global ragweed pollen allergy treatment market. For instance, globally, as of 5:10pm CET, 9 February 2021, there have been 106,125,682 confirmed cases of COVID-19, including 2,320,497 deaths, reported to the World Health Organization. Moreover, initiatives to release comprehensive guides for management of allergies and related diseases during the pandemic is also expected to aid in growth of the market. For instance, in July 2020, Asthma and Allergy Foundation of America released a comprehensive guide, the “COVID-19 and Asthma Toolkit for Schools” to help educators and families of children living with asthma navigate best methods to stay healthy for those returning to classrooms during the COVID-19 pandemic.

Competitive Analysis

Major players operating in the global ragweed pollen allergy treatment market include, ALK-Abello A/S, ASIT Biotech SA, Anergis SA, Biomay AG, and Astellas Pharma Inc., Thermo Fisher Scientific Inc, Siemens Healthcare Private Limited, Omega Diagnostics Group PLC, Stallergenes Greer, bioMerieux SA, Lincoln Diagnostics, Inc., HOB Biotech Group Corp Ltd, HYCOR Biomedical, Inc., Alcon, Hitachi Chemical Diagnostics, Inc., Quest Diagnostics Incorporated, Circassia, Immunomic Therapeutics, Inc., Novartis AG, Japan Tobacco Inc., GlaxoSmithKline plc, ALK, REGiMMUNE Co, Ltd, Sanofi, and Merck KGaA.

Major players operating in the global ragweed pollen allergy treatment market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2020, ALK received Health Canada approval for once-daily ITULATEKTM (standardised allergen extract, white birch (betula verrucosa) sublingual tablet) for the treatment of tree pollen allergy.

Comments

Post a Comment

Popular posts from this blog

Global Biofeedback Measurement Instrument Market to Rise During the COVID-19 Crisis Period Owing to Increasing Consumer Awareness

Image
  Increasing cases of neurological disorders, including depression, anxiety, ADHD, and other dementias, are expected to fuel the market growth of the biofeedback instrument market during the forecast period. For example, according to the World Alzheimer's Study released by Alzheimer's Disease International (ADI), new cases of dementia across regions in 2015 were 4.9 million (49.0 percent) in Asia Pacific, 2.5 million (25.0 percent) in Europe, 1.7 million (18.0 percent) in the Americas and 0.8 million (8.0 per cent) in Africa. In addition, according to Parkinson's UK, about 137,000 people in the UK suffered from Parkinson's disease in 2015. Parkinson's disease is the second most common age-related neurodegenerative condition after Alzheimer's. For example, according to Parkinson's UK, the estimated number of people with Parkinson's disease in Northern Ireland in 2015 was 241, 157 of whom were male and 85 were female. The global biofeedback instrument mark...
Read more

Global Pro AV Market from Key End-use Sectors to Surge in the Near Future

 Overview of the market  Pro AV refers to the sophisticated integration of audio-video devices used for commercial purposes. Pro AV uses multiple aspects such as display components, cameras, audio components, monitors, controls, space planners, whiteboard companions, advanced features such as digital signage, and other supporting accessories. Both of these components help to enhance connectivity and coordination between offices in two separate locations. It is therefore used in a number of industries, including education, government, hospitality/retail, and others.  The global Pro AV market was estimated at US$ 246.5 billion in 2019 and is projected to have a CAGR of 11.2 per cent during the forecast years (2020-2027).  Market Trend The integration of telecommunications applications including such Skype is a big trend in the global Pro AV industry.  The main players on the market are the integration of Pro AV products with telecommunications applications such as...
Read more